[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PHIO":3,"homepage-market-summary":30,"stock-news-PHIO":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PHIO","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Phio Pharmaceuticals Corp. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.","6","King Of Prussia, PA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":17,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},0.9995,0.9944,1.02,0.9701,0.0051,0.51,91588.566091,373,0.9919,4.19,0.81300002,1863422.5998829203,5.5,3622,{"status":31,"indices":32,"watchlist":75,"sectors":97,"benchmarks":152},"success",[33,40,47,54,60,67],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":14,"sparkline":39,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":14,"sparkline":46,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":14,"sparkline":53,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":38,"is_up":14,"sparkline":59,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":14,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":73,"sparkline":74,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":14,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":73,"sparkline":89,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":14,"sparkline":96,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[98,103,108,113,118,123,128,133,138,142,147],{"name":99,"etf":100,"change":101,"price":102,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":104,"etf":105,"change":106,"price":107,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":109,"etf":110,"change":111,"price":112,"is_up":73},"Healthcare","XLV",1.03,168.81,{"name":114,"etf":115,"change":116,"price":117,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":119,"etf":120,"change":121,"price":122,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":124,"etf":125,"change":126,"price":127,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":129,"etf":130,"change":131,"price":132,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":134,"etf":135,"change":136,"price":137,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":139,"etf":140,"change":65,"price":141,"is_up":14},"Real Estate","XLRE",40.57,{"name":143,"etf":144,"change":145,"price":146,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":148,"etf":149,"change":150,"price":151,"is_up":14},"Comm Services","XLC",-0.35,111.26,[153,158,163,168],{"ticker":154,"name":155,"price":156,"change":157,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":159,"name":160,"price":161,"change":162,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":164,"name":165,"price":166,"change":167,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":169,"name":170,"price":171,"change":65,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":173,"articles":174},15,[175,181,187,192,198,204,210,214,219,224,229,234,239,244,249],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"A cancer approach designed to help immune cells fight tumors is the focus of Phio's presentation. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOSHZjZXNGMXlMVzd4dTcyQXI2bjQ5MmV0Sll2eXRkZlgydHVPSEVTaFFYcmpKeGxMMlNMY1BIS01iX1daSGNqMlVZbW96aXNiTW14a2FFWkVVOWw2NmZyX0syM3BNZWxsTXcwV2dib2k1bGhNNnppOExlSzV1TTZ3SHl4Wk5UYnczY0JDTHdMSzdFdU42ME5OaWttRUFXeks4TGhrVUwtQ2VBcGtnSFV2ZmU3NGYyRnNnWWpTUFJDQQ?oc=5","Tue, 06 Oct 2026 11:00:00 GMT","A cancer approach designed to help immune cells fight tumors is the focus of Phio's presentation. Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigFBVV95cUxPZnJLNWtkNHJPV3hnUjRZMXpNU2VrQzlWaE5xdC1oNWR3Qk1hU2h5NUZ5U2VCblJQSjdoZmNhVGJpRU1hNEpGLXp4QlhRaHJ2TG5JMlRROFZ6OGZ2Wnlic29KZXdpNThmSXk4SXN2T01iRzRZYmpyT0hvcVBnVThSbTRwUGFSd3Q4QlE?oc=5","Mon, 05 Oct 2026 14:56:25 GMT","Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target Yahoo Finance","Yahoo Finance",{"title":188,"link":189,"pubDate":190,"description":191,"source":180},"A planned Florida talk will cover Phio's skin cancer program - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPZUw1X0l5ZUQ4OVRLMTNHd3F2R1NDVUt4MzJEYmdXalQ3azZGVTZKcllSMTNGVW9TbHI2WlJyV2hJRmdnQThUVVhPLUN6eEFGNkk0d0ZHM1ZnOEtMUVgtSGNnYWRWYkpULWc1aWxzUFVoYjkyX012X3loS1hlM214Nk5JbDZkMWZBQ0ppejBFWk1IOHNUWGlubkM5VE9xMWNwaGRlbi1nZjNGU1NxdWU3Z29ESjBXUm5aQW9MTnZn?oc=5","Mon, 05 Oct 2026 11:00:00 GMT","A planned Florida talk will cover Phio's skin cancer program Stock Titan",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"Phio Pharmaceuticals Director Ronald Todd Plott Granted 17,000 Restricted Stock Units - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxQQ0h0Vk9wX0hLZGV3SWtBMUNhN2xzUHZNV3hTWWRtRXJqMGRyUkVnSEhVY19IRmtWV0tMenFYd290emU5VFN4VmRLUjdJcFAyM0NGVXdRaDQ0aS1TYU9BSllrREhCbzBPOU1ET2VwZENENkRoVWJQU1pYaE9hZ2pfeDUzM2xqekR2bEVyb0FvaFJhZmtFQjdhTGFwTTFpX3RyZUVWcmgzVXVfcTZnQXZKZHdFTU1HZFBVanVfSHN6UEtDTVZFSEhCRTlpQQ?oc=5","Tue, 29 Sep 2026 20:03:41 GMT","Phio Pharmaceuticals Director Ronald Todd Plott Granted 17,000 Restricted Stock Units Kalkine Media","Kalkine Media",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference - www.marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxNb1hSQzFfenZXUVVGQzBYcngxd1AtclI3Zl9TRzB0MXhPMzAxZllhMlNlWGRyRkRVcVZkN09pSENHd3JYbWVJZ1VGZ0ZQSkRBaG93TnJVQ3hyU2RZblF6ZTY5SFJwSUViYTZ4cUxwRHVuWHFhUGJxYU1NeWZidkdsNGtXTXVCNEZiVlkyby1Da1lLaFBLUE1tVk9nMWdCd2Q0NHd6TmNWdDFVLXZYcVZLUm80LVdEUXZwOEpUX1ZnNjRhcHhyTGFhS0M4SU1JTTZZNlhKVVhjRGVxMEJaZ1RSZG5vanVPQQ?oc=5","Mon, 05 Oct 2026 11:02:05 GMT","Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference www.marketscreener.com","www.marketscreener.com",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"Phio Pharmaceuticals (PHIO) Slips 1.50% to $0.98, Testing Support Near $0.93 - ALMA Signal - https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxPczVhM08xaGVnRE9KSmRSc2x1akp0N2JJa0NXcjE3bzJZMGtIajBtR2pJOHRncUs4ZDhNRzNaejJSTTZvZU9hcElZaTVqTUt3Smh1ODl6bDNhZVZYaUZHcjduWmhHUGFzUHVBVGFabFBITUkzSjlkdldWLTJEZVI0djhMSmhnT1ViYWhMZGduUm1FaEhpQ1p3Q3ctY1ZIeUVMM01GLURPZ0k2MlpiaXY4?oc=5","Sat, 03 Oct 2026 17:37:44 GMT","Phio Pharmaceuticals (PHIO) Slips 1.50% to $0.98, Testing Support Near $0.93 - ALMA Signal https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fwww.siam.in\u002F",{"title":211,"link":212,"pubDate":178,"description":213,"source":186},"Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026 - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQRUxDMWt2U1dDNm5hOGd2SEh6S2RFN2RzMnl0eE00YzNpQUFxS21iZ1ZFaDNFenpxRTBxZDg4Z1BFSUxNRWQtbEU2TFl6ajQ1dENSTjdMU1JRdHkwQmthREdpR29ZTFIzNVFBd1lWRUdXXzZNUHptQ29GbkRFaEl0Sjd6X3UwRS1RcndfTlhjUUJNbmU4MGtJcUlDQnB4YmpmRmJia1hlUQ?oc=5","Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026 Yahoo Finance",{"title":215,"link":216,"pubDate":217,"description":218,"source":180},"At $1.0127 a share, a Phio Pharmaceuticals (PHIO) director bought 6,500 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNdGZvbDJ5Q0M3d3dmd1hYc2JwNTRyV3lqLXBVQy1SSU40Wl9nZzlyZ3dmdUtVSTI3N0o0MVc4THc1Y2FucVNsMVlFWkh4U0VWejhLdnMtb3lRaUkwMXNmMVpmaEVMUWo4REl1NDRWOG5tVi04Y2Z0Nl9QSkUzRlVSbi10M0pQUlR6NlA2NEpSUmpLNkd5VG4tM2VEa0NEU3JyYy1Pd21iSTU0Rl8zTWlXc00wRFJ1TExwaXVV?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","At $1.0127 a share, a Phio Pharmaceuticals (PHIO) director bought 6,500 shares. Stock Titan",{"title":220,"link":221,"pubDate":222,"description":223,"source":197},"Phio Pharmaceuticals CFO Lisa Cabott Carson Granted 108,000 Restricted Stock Units - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxQOTVHeWU1Z0phMWxqVXYyQ0JpRjNTdGJaOFp4d2pjWUg3YUlLbEgtMFNkUU0yN3lzRkRqZkRIR2d4aVZxTHVDVzZOWV9GdUxfenFuT3g4NnBYUVB3U0F3cVlaZEFqZ0E0T3JVQnZMVVhNamZ4NjBna3Z3YndYeEYyWU9ZcVhJWXdlMVZYU2JkUEdWeEJ3bjFQMjZ4YVFMbDZ2OXM5OWxfc1FRakhlcjQydUx0OFFLNWhzdW9HM0RESFV1ZTVUbWFJ?oc=5","Tue, 29 Sep 2026 20:03:39 GMT","Phio Pharmaceuticals CFO Lisa Cabott Carson Granted 108,000 Restricted Stock Units Kalkine Media",{"title":225,"link":226,"pubDate":227,"description":228,"source":180},"A CEO's stock award will vest after a year at Phio Pharmaceuticals (PHIO). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOXzkwbl83Vi1yV19qdHZvUC1pY3ozZ2hld0FtdDRnMmcyZ2Y2UVEtR0RwUk1UNFh2RUQzQ0VrV3hBcVgzdmJxek1kejBzU3c2Mzhma2JiT1ZoNjU3VXBTeHdJS1lzSXg2bENyMnQxQ1VRbEdfd3ZHNVA5b3ZsQVA3LVFyaEljcDNXekdMTExnNjBLQW12Z2VhQVczUmhITV9McjRjdFVSYkdsRjdoOXlXRFpxM1l1NndNU013?oc=5","Tue, 29 Sep 2026 20:01:31 GMT","A CEO's stock award will vest after a year at Phio Pharmaceuticals (PHIO). Stock Titan",{"title":230,"link":231,"pubDate":232,"description":233,"source":209},"PHIO Q2 2026 Earnings: Loss Per Share Comes In Narrower Than Expected as Clinical-Stage Story Holds - Pre-Announcement Alert - https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1wFBVV95cUxOa2luZzZhYzVmdUw4ZlY4WkdFU3lNV1JldldZTFZjUEE3Mk5pWUhZT3hRaXZVd2YtOUpQLWs0Y3JYS2JBc2VYN1ZwekNzVlowaWY0S0ozbXpjTHd3aFFUQVVVNVRXaWJWcUpwamZsUl9ZVXlUMV9oMFBMbDljOVBEWmZlcmJtbEd0bFhONS1YcjBta3k5cFY4WlJLTDRYQ0JPS3gwOURueVplQ282SGJCd2pFR0JMZ1Q3Sjk4WE5vRWNhdDJIRU5zN1hxelE5SW16ZEV2a0p0VQ?oc=5","Wed, 30 Sep 2026 12:30:30 GMT","PHIO Q2 2026 Earnings: Loss Per Share Comes In Narrower Than Expected as Clinical-Stage Story Holds - Pre-Announcement Alert https:\u002F\u002Fwww.siam.in\u002F",{"title":235,"link":236,"pubDate":237,"description":238,"source":197},"Phio Pharmaceuticals CEO Robert J. Bitterman Awarded 400,000 Restricted Stock Units - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxPendFZWRyTUZ6Z3hFSE9ocXVwc2FrVHJTSzBvdWhMMF9NNFlKTUYzeVl2RGYtZjRIMTdsVmpvckYtRUlGX0tHVGt5LWtCNFh3WEgtS29CNkhXZUhRSGdnRHZCUlZRdURWWm5aN29PRXZKREtQMzFvMTc4Ull5YUY0bmtsQXFaYW5XSV96dC04VVRkdzl6X3dEUFFXRzhZbkVEQmx0dVh6TzB5VzVrUVFyWEstR0JJazhidTdyS0FXVkNzbGp3TnJZ?oc=5","Tue, 29 Sep 2026 20:03:23 GMT","Phio Pharmaceuticals CEO Robert J. Bitterman Awarded 400,000 Restricted Stock Units Kalkine Media",{"title":240,"link":241,"pubDate":242,"description":243,"source":180},"A director’s grant at Phio Pharmaceuticals (PHIO) covers 17,000 shares that vest in a year. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOcjFSU3p4WDNoeDlYUk1FRk1vRi1USWU5dElZTVZoUU5aaEFyb2c5MnVvdWU4cWlNbzZWNnhfRmtUcVR3VVdHRlN1MktKdkdfbC1GNk5BUlo5cEVmUWFyU01ncHAxVEZMbUhQQWR5eFZsaUx3OTcycGJuVlNJZEZRTUdGYlgtbHNOZFllcHRabE5PYWtfQzd1V2JzS0t5TWI2ZEtHUVk5cWIyZF84MlpHNkRvNzUyWHB3UFhJ?oc=5","Tue, 29 Sep 2026 20:01:32 GMT","A director’s grant at Phio Pharmaceuticals (PHIO) covers 17,000 shares that vest in a year. Stock Titan",{"title":245,"link":246,"pubDate":247,"description":248,"source":197},"Phio Pharmaceuticals Stockholders Endorse 2026 Annual Meeting Proposals Including Director Elections and Incentive Plan Expansion - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihwJBVV95cUxPN2w3WW9vcnJkWVFoNDdKcjE1VVUydXhsQzRmZDBoNlZHdnJqenh1SlRvcWN5cFoyRXZ4UHg1ODFZT05HQzFRckRKTXZfejJnWGRGb0x3em5hWmFCRkVUZFR0Nk8tZmVGc1lpWXUtWUdvQTVkRzlaNERnLTc4MkF4VzBWaU1QWFZZOW5zaTBBRUFNTnJmenc2bEtvMFM2MExyczM0OUtERE52a28xQnkwVWE3WlQ5RUU1Q2Z2eU1SVFl3N2NIMTEwcmE2Uy1uczJqSDFrdU5UY1NacEpUUjVwVDRGM2ptbUZSb1N6VkM0bE9NcUJ4dmw1WUZiZktyb0g5a2lfOEJmYw?oc=5","Tue, 29 Sep 2026 03:24:18 GMT","Phio Pharmaceuticals Stockholders Endorse 2026 Annual Meeting Proposals Including Director Elections and Incentive Plan Expansion Kalkine Media",{"title":250,"link":251,"pubDate":252,"description":253,"source":180},"A director buys 10,000 shares of Phio Pharmaceuticals (PHIO) at $1.03 and $1.04 per share. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOSThrNkk3WXlpTnZzR0VPem4tWkwxTlhfZmUwcldicm9Tdkw2am1hTUxtWVU0ZkNES1B0YVJNazRJalg1NGxnWEFTVXVoX08xRFV2eFhPbmFxcjRJbXBZTFQ4a3NDdTE5aU5PZDhFMHFMVVZDUF80c0hoOFJyTm8xdVRMUTYxNGJ5TUNrTHZIanFUU1VFbXZiWHVWb3lUWkd4QlBmV0RMVkJIc1Q0empHeFlmNVhDMklZNTkw?oc=5","Wed, 30 Sep 2026 20:01:31 GMT","A director buys 10,000 shares of Phio Pharmaceuticals (PHIO) at $1.03 and $1.04 per share. Stock Titan"]